G
GRI
GRI Bio
2.300
-0.110-4.56%Pre Market: 2.450 +0.150 +6.52%04:26 04/08 EDT
OPEN/PREV CLOSE2.340/2.410
TODAY RANGE2.140-2.430
VOL81
MARKET CAP3.32M
52 WEEK RANGE2.100-80.36
AVG VOL (3M)356.12K
% TURNOVER0.95%
TURNOVER0
P/E (TTM)-0.0189
% RANGE12.03%
EPS(TTM)-121.8011
P/E(FORWARD)-0.1496
P/B0.1905
BVPS12.07
DIVIDEND--
P/S476.19
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.30M
SHARES OUTSTANDING1.45M
NEXT EARNINGS05/13-05/18
FREE FLOAT1.44M
LOT SIZE1
EX-DATE01/26/2026
News
Press Releases
Financial Reports
Profile
Benzinga·20h ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Dow Jones·03/11 12:52
GRI Bio Price Target Cut to $40.00/Share From $1008.00 by Ascendiant Capital
Dow Jones·03/11 12:52
GRI Bio Is Maintained at Buy by Ascendiant Capital
Benzinga·03/11 12:44
Ascendiant Capital Maintains Buy on GRI Bio, Lowers Price Target to $40
Reuters·02/17 14:15
GRI Bio Reports Positive Phase 2a Results in Idiopathic Pulmonary Fibrosis
Reuters·02/05 14:15
GRI Bio to Present at Webull Financial Corporate Connect Webinar Series
Seeking Alpha·02/04 14:29
GRI Bio reports FY results
Reuters·02/04 13:56
GRI Bio raises $14.5 mln to fund operations into Q1 2027
Benzinga·02/04 13:56
GRI Bio FY25 Net Loss $12M
TipRanks·02/04 13:50
GRI Bio sees cash runway into 1Q27
Reuters·02/04 13:45
Gri Bio Inc. reports FY 2025 cash and cash equivalents of USD 8.2 million
TipRanks·01/30 11:38
GRI Bio Expands At-The-Market Equity Offering Capacity
Same Industry
Name/Symbol
Change%
Price